Arbutus to Present at Upcoming May 2019 Conferences
May 13 2019 - 8:30AM
Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading
Hepatitis B Virus (HBV) therapeutic solutions company, today
announced that Dr. Mark J. Murray, Arbutus’ President and CEO, will
present at the following conferences in May 2019:
UBS Global Healthcare Conference – New York |
Monday, May 20, 2019, 1:00 PM ET |
|
|
RBC Capital Markets
Healthcare Conference – New York |
Tuesday, May 21, 2019, 11:00 AM
ET |
Live webcasts of the presentations can be
accessed through the Investors section of Arbutus' website at
www.arbutusbio.com. A replay of the webcasts will be
available for 90 days following the live
presentations.
About Arbutus
Arbutus Biopharma Corporation is a
publicly-traded (Nasdaq: ABUS) biopharmaceutical company dedicated
to discovering, developing, and commercializing a cure for patients
suffering from chronic Hepatitis B infection. Arbutus is developing
multiple drug candidates, each of which have the potential to
improve upon the standard of care and contribute to a curative
combination regimen. For more information, visit
www.arbutusbio.com.
Contact Information
Investors
Mark MurrayPresident and CEOPhone: 604-419-3200 Email:
ir@arbutusbio.com
Pam Murphy Investor Relations ConsultantPhone:
604-419-3200Email: ir@arbutusbio.com
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Apr 2023 to Apr 2024